Below are the earnings highlights for Alexion Pharmaceuticals Inc. (ALXN):
-Net Income: $297.73 Mln in Q2 vs. $299.07 Mln in the same period last year.
-EPS: $1.44 in Q2 vs. $1.12 in the same period last year.
-Revenue: $636.21 Mln in Q2 vs. $512.50 Mln in the same period last year.
-Guidance:
Full year EPS guidance: $4.70 - $4.80
Full year revenue guidance: $2.6 - $2.62 Bln
For comments and feedback contact: editorial@rttnews.com